{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:18:41Z","timestamp":1761844721601},"reference-count":54,"publisher":"Japan Atherosclerosis Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2017]]},"DOI":"10.5551\/jat.37507","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T22:16:33Z","timestamp":1490307393000},"page":"1075-1084","source":"Crossref","is-referenced-by-count":26,"title":["Design of the Familial Hypercholesterolaemia Australasia Network Registry: Creating Opportunities for Greater International Collaboration"],"prefix":"10.5551","volume":"24","author":[{"given":"Matthew I","family":"Bellgard","sequence":"first","affiliation":[{"name":"Centre for Comparative Genomics, Murdoch University, Murdoch"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline E","family":"Walker","sequence":"additional","affiliation":[{"name":"Office of Population Health Genomics, Public Health Division, Department of Health, Government of Western Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn R","family":"Napier","sequence":"additional","affiliation":[{"name":"Centre for Comparative Genomics, Murdoch University, Murdoch"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leanne","family":"Lamont","sequence":"additional","affiliation":[{"name":"Office of Population Health Genomics, Public Health Division, Department of Health, Government of Western Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam A","family":"Hunter","sequence":"additional","affiliation":[{"name":"Centre for Comparative Genomics, Murdoch University, Murdoch"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Render","sequence":"additional","affiliation":[{"name":"Centre for Comparative Genomics, Murdoch University, Murdoch"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Radochonski","sequence":"additional","affiliation":[{"name":"Centre for Comparative Genomics, Murdoch University, Murdoch"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Pang","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Pedrotti","sequence":"additional","affiliation":[{"name":"Familial Hypercholesterolaemia Family Support Group of Western Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Sydney Medical School, University of Sydney"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam","family":"Kostner","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Queensland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warrick","family":"Bishop","sequence":"additional","affiliation":[{"name":"Menzies Institute for Medical Research, University of Tasmania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M","family":"George","sequence":"additional","affiliation":[{"name":"Canterbury Health Laboratories, University of Otago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Austin Clinical School, University of Melbourne"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M","family":"Clifton","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Medical Sciences, University of South Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank M Van","family":"Bockxmeer","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital"},{"name":"School of Surgery, University of Western Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J","family":"Nicholls","sequence":"additional","affiliation":[{"name":"South Australian Health and Medical Research Institute, University of Adelaide"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Hamilton-Craig","sequence":"additional","affiliation":[{"name":"School of Medicine, Flinders University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh JS","family":"Dawkins","sequence":"additional","affiliation":[{"name":"Centre for Comparative Genomics, Murdoch University, Murdoch"},{"name":"Office of Population Health Genomics, Public Health Division, Department of Health, Government of Western Australia"},{"name":"Centre for Population Health Research, Curtin University of Technology"},{"name":"School of Pathology and Laboratory Medicine, University of Western Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald F","family":"Watts","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia"},{"name":"Lipid Disorders Clinic, Cardiometabolic Service, Royal Perth Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Watts GF, Shaw JE, Pang J, Magliano DJ, Jennings G, Carrington MJ: Prevalence and treatment of familial hypercholesterolaemia in Australian communities. Int J Cardiol, 2015; 185: 69-71","DOI":"10.1016\/j.ijcard.2015.03.027"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG: Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab, 2012; 97: 3956-3964","DOI":"10.1210\/jc.2012-1563"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Goldstein JL, Brown MS: The LDL receptor. Arterioscler Thromb Vasc Biol, 2009; 29: 431-438","DOI":"10.1161\/ATVBAHA.108.179564"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Austin MA, Hutter CM, Zimmern RL, Humphries SE: Genetic causes of monogenic heterozygous familial hyper-cholesterolemia: a HuGE prevalence review. Am J Epidemiol, 2004; 160: 407-420","DOI":"10.1093\/aje\/kwh236"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Cuchel M, Bruckert E, Ginsberg HN, Raal FJ, Santos RD, Hegele RA, Kuivenhoven JA, Nordestgaard BG, Descamps OS, Steinhagen-Thiessen E: Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J, 2014; 35: 2146-2157","DOI":"10.1093\/eurheartj\/ehu274"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC: Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. Eur Heart J, 2013; 34: 3478-3490","DOI":"10.1093\/eurheartj\/eht273"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Pang J, Lansberg PJ, Watts GF: International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next? J Atheroscler Thromb, 2016; 23:505-519","DOI":"10.5551\/jat.34108"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Versmissen J, Oosterveer DM, Yazdanpanah M, Defesche JC, Basart DC, Liem AH, Heeringa J, Witteman JC, Lansberg PJ, Kastelein JJ: Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ, 2008; 337: a2423","DOI":"10.1136\/bmj.a2423"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Harada-Shiba M, Sugisawa T, Makino H, Abe M, Tsushima M, Yoshimasa Y, Yamashita T, Miyamoto Y, Yamamoto A, Tomoike H: Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia. J Atheroscler Thromb, 2010; 17: 667-674","DOI":"10.5551\/jat.4143"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Raal FJ, Santos RD: Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment. Atherosclerosis, 2012; 223: 262-268","DOI":"10.1016\/j.atherosclerosis.2012.02.019"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Watts GF, Sullivan DR, Poplawski N, van Bockxmeer F, Hamilton-Craig I, Clifton PM, O\u2019Brien R, Bishop W, George P, Barter PJ: Familial hypercholesterolaemia: a model of care for Australasia. Atheroscler Suppl, 2011; 12: 221-263","DOI":"10.1016\/j.atherosclerosissup.2011.06.001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Watts GF, George P, Hagger MS, Hu M, Lin J, Lin KK, Marais AD, Miida T, Nawawi HM, Pang J, Park E, Gonzalez-Santos LB, Su TC, Troung TH, Santos RD, Soran H, Yamashita Y, Tomlinson B: Translational Research for Improving the Care of Familial Hypercholesterolaemia: The \u201cTen Countries Study\u201d and Beyond. J Atheroscler Thromb, 2016; 23: 891-900","DOI":"10.5551\/jat.35949"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Hamilton-Craig I, Watts G, Hammond E, Sullivan D, George P, Clifton P, Nicholls S, van Bockxmeer F, Bishop W, O\u2019Brien R, Bell D: Establishing an Australian and New Zealand Registry for Patients with Familial Hypercholesterolaemia. Heart Lung Circ, 2013; 22: S229","DOI":"10.1016\/j.hlc.2013.05.543"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Defesche JC: Defining the challenges of FH screening for familial hypercholesterolemia. J Clin Lipidol, 2010; 4: 338-341","DOI":"10.1016\/j.jacl.2010.08.022"},{"key":"15","unstructured":"15) Watts G, Dimmitt S, Redgrave T, Bates T, Emery J, Burnett J, van Bockxmeer F, Poke S, Maxwell S, O\u2019Leary P: Model of Care: Familial Hypercholesteroleamia, Perth, Western Australia, 2008"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M: Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int J Cardiol, 2014; 171: 309-325","DOI":"10.1016\/j.ijcard.2013.11.025"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Hammond E, Watts GF, Rubinstein Y, Farid W, Livingston M, Knowles JW, Lochm\u00fcller H, Bellgard M, Dawkins HJ: Role of international registries in enhancing the care of familial hypercholesterolaemia. Int J Evid Based, 2013; 11: 134-139","DOI":"10.1111\/1744-1609.12023"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Bellgard MI, Beroud C, Parkinson K, Harris T, Ayme S, Baynam G, Weeramanthri T, Dawkins H, Hunter A: Dispelling myths about rare disease registry system development. Source Code Biol Med, 2013; 8: 21","DOI":"10.1186\/1751-0473-8-21"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Young AS, Chaney E, Shoai R, Bonner L, Cohen AN, Doebbeling B, Dorr D, Goldstein MK, Kerr E, Nichol P: Information technology to support improved care for chronic illness. J Gen Intern Med, 2007; 22: 425-430","DOI":"10.1007\/s11606-007-0303-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Bodenheimer T: Interventions to improve chronic illness care: evaluating their effectiveness. Dis Manag, 2003; 6: 63-71","DOI":"10.1089\/109350703321908441"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Bufalino VJ, Masoudi FA, Stranne SK, Horton K, Albert NM, Beam C, Bonow RO, Davenport RLV, Girgus M, Fonarow GC: The American Heart Association\u2019s recommendations for expanding the applications of existing and future clinical registries a policy statement from the American Heart Association. Circulation, 2011; 123: 2167-2179","DOI":"10.1161\/CIR.0b013e3182181529"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Mundal L, Retterst\u00f8l K: A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries. Curr Opin Lipidol, 2016; 27: 388-397","DOI":"10.1097\/MOL.0000000000000300"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Humphries SE, Whittall RA, Hubbart CS, Maplebeck S, Cooper JA, Soutar A, Naoumova R, Thompson GR, Seed M, Durrington PN: Genetic causes of Familial Hypercholesterolaemia in UK patients: relation to plasma lipid levels and coronary heart disease risk. J Med Genet, 2006; 43: 943-949","DOI":"10.1136\/jmg.2006.038356"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Neil A, Cooper J, Betteridge J, Capps N, McDowell I, Durrington P, Seed M, Humphries SE: Reductions in allcause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J, 2008; 29: 2625- 2633","DOI":"10.1093\/eurheartj\/ehn422"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Neil H, Hammond T, Huxley R, Matthews D, Humphries S: Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ, 2000; 321: 148","DOI":"10.1136\/bmj.321.7254.148"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Ramaswami U, Cooper J, Humphries SE: The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data. Arch Dis Child, 2017; 102: 255-260","DOI":"10.1136\/archdischild-2015-308570"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ, Scheerder RL, Kastelein JJ: Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet, 2001; 357: 165-168","DOI":"10.1016\/S0140-6736(00)03587-X"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Toleikyte I, Retterst\u00f8l K, Leren TP, Iversen PO: Pregnancy Outcomes in Familial Hypercholesterolemia A Registry-Based Study. Circulation, 2011; 124: 1606-1614","DOI":"10.1161\/CIRCULATIONAHA.110.990929"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30) Mundal L, Veier\u00f8d MB, Halvorsen T, Holven KB, Ose L, Iversen PO, Tell GS, Leren TP, Retterst\u00f8l K: Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994\u20132009, a registry study. Eur J Prev Cardiol, 2016; 2047487316666371","DOI":"10.1177\/2047487316666371"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31) O\u2019Brien EC, Roe MT, Fraulo ES, Peterson ED, Ballantyne CM, Genest J, Gidding SS, Hammond E, Hemphill LC, Hudgins LC: Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry. Am Heart J, 2014; 167: 342-349","DOI":"10.1016\/j.ahj.2013.12.008"},{"key":"31","doi-asserted-by":"publisher","unstructured":"32) deGoma EM, Ahmad ZS, O\u2019Brien EC, Kindt I, Shrader P, Newman CB, Pokharel Y, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD: Treatment Gaps in Adults with Heterozygous Familial Hypercholesterolemia in the United States: Data from the CASCADE-FH Registry. Circ Cardiovasc Genet, 2016; doi: 10.1161\/CIRCGENETICS.116.001381","DOI":"10.1161\/CIRCGENETICS.116.001381"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33) Williams RR, Hamilton-Craig I, Kostner GM, Hegele RA, Hayden MR, Pimstone SN, Faergeman O, Schuster H, Steinhagen-Thiessen E, Beisiegel U, Keller C, Czeizel AE, Leitersdore E, Kastelein JC, Defesche JJP, Ose L, Leren TP, Seftel HC, Raal FJ, Marais AD, Eriksson M, Keller U, Miserez AR, Jeck T, Betterridge DJ, Humphries SE, Day INM, Kwiterovich PO, Lees RS, Stein E, Illingworth R, Kane J, Boulyjenkov V: MED-PED: An Integrated Genetic Strategy for Preventing Early Deaths. In: Genetic Approaches to Noncommunicable Diseases, ed by Berg K, Boulyjenkov V, and Christen Y, pp35-45, Springer Berlin Heidelberg, Berlin, Heidelberg, 1996","DOI":"10.1007\/978-3-642-61028-8_5"},{"key":"33","unstructured":"34) Wong S, Taraboanta C, Francis GA, Ignaszewski A, Frohlich J: The British Columbia Familial Hypercholesterolemia Registry. BCMJ, 2013; 55: 326-330"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35) Mata P, Alonso R, P\u00e9rez-Jim\u00e9nez F: Screening for Familial Hypercholesterolemia: a Model for Preventive Medicine. Rev Esp Cardiol, 2014; 67: 685-688","DOI":"10.1016\/j.rec.2014.01.015"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36) Mata N, Alonso R, Badim\u00f3n L, Padr\u00f3 T, Fuentes F, Mu\u00f1iz O, Perez-Jim\u00e9nez F, L\u00f3pez-Miranda J, D\u00edaz JL, Vidal JI: Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART). Lipids Health Dis, 2011; 10: 94","DOI":"10.1186\/1476-511X-10-94"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37) Bamimore MA, Zaid A, Banerjee Y, Al-Sarraf A, Abifadel M, Seidah NG, Al-Waili K, Al-Rasadi K, Awan Z: Familial hypercholesterolemia mutations in the Middle Eastern and North African region: A need for a national registry. J Clin Lipidol, 2015; 9: 187-194","DOI":"10.1016\/j.jacl.2014.11.008"},{"key":"37","unstructured":"38) B\u00e9liard S, Millier A, Bruckert \u00c9: A French cohort of patients with familial hypercholesterolemia. 11\u00e8me congr\u00e8s NSFA, 2015; http:\/\/www.creativ-ceutical.com\/sites\/default\/files\/NSFA_2015_17-4_French_cohort_familial_ hypercholesterolemia.pdf"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39) Vallejo-Vaz AJ, Kondapally SS, Cole D, Hovingh GK, Kastelein J, Mata P, Raal FJ, Santos RD, Soran H, Watts GF: Familial hypercholesterolaemia: A global call to arms. Atherosclerosis, 2015; 243: 257","DOI":"10.1016\/j.atherosclerosis.2015.09.021"},{"key":"39","unstructured":"40) PASS Software: PASS Clinical Vascular. 2010; 2015: http:\/\/www.pass-software.com\/Producten\/PASSClinical- Vascular\/tabid\/116\/language\/en-US\/Default.aspx"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41) Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG: Research electronic data capture (REDCap)\u2014 a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform, 2009; 42: 377-381","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"41","unstructured":"42) TREAT-NMD: Registries tool kit. 2015; http:\/\/www. treat-nmd.eu\/resources\/patient-registries\/tookit\/"},{"key":"42","unstructured":"43) EURORDIS-NORD-CORD: Joint Declaration 10 Key Principles of Rare Disease Patient Registries. 2012; http:\/\/ download.eurordis.org\/documents\/pdf\/EURORDIS_ NORD_CORD_JointDec_Registries_FINAL.pdf"},{"key":"43","unstructured":"44) EUCERD: Core Recommendations on Rare Disease Patient Registration and Data Collection. 2013; http:\/\/ www.eucerd.eu\/wp-content\/uploads\/2013\/06\/EUCERD_Recommendations_RDRegistryDataCollection_adopted.pdf"},{"key":"44","doi-asserted-by":"crossref","unstructured":"45) Bellgard MI, Sleeman MW, Guerrero FD, Fletcher S, Baynam G, Goldblatt J, Rubinstein Y, Bell C, Groft S, Barrero R: Rare Disease Research Roadmap: Navigating the bioinformatics and translational challenges for improved patient health outcomes. Health Pol Tech, 2014; 3: 325-335","DOI":"10.1016\/j.hlpt.2014.08.007"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46) Lindoerfer D, Mansmann U: A Comprehensive Assessment Tool for Patient Registry Software Systems: The CIPROS Checklist. Methods Inf Med, 2015; 54: 447-454","DOI":"10.3414\/ME14-02-0026"},{"key":"46","doi-asserted-by":"crossref","unstructured":"47) Thompson R, Johnston L, Taruscio D, Monaco L, B\u00e9roud C, Gut IG, Hansson MG, Peter-Bram A, Patrinos GP, Dawkins H: RD-Connect: an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research. J Gen Intern Med, 2014; 29: 780-787","DOI":"10.1007\/s11606-014-2908-8"},{"key":"47","doi-asserted-by":"crossref","unstructured":"49) Bellgard MI, Render L, Radochonski M, Hunter A: Second generation registry framework. Source Code Biol Med, 2014; 9: 14","DOI":"10.1186\/1751-0473-9-14"},{"key":"48","unstructured":"50) Bellgard MI, Napier K, Render L, Radochonski M, Lamont L, Graham C, Wilton SD, Fletcher S, Goldblatt J, Hunter AA, Weeramanthri T: A Registry Framework Enabling Patient-Centred Care. Stud Health Technol Inform, 2015; 214: 8-14"},{"key":"49","doi-asserted-by":"publisher","unstructured":"51) Napier KR, Pang J, Lamont L, Walker CE, Dawkins HJS, Hunter AA, van Bockxmeer FM, Watts GF, Bellgard MI: A web-based registry for familial hypercholesterolaemia. Heart Lung Circ, 2017; doi: 10.1016\/j.hlc.2016.10.019","DOI":"10.1016\/j.hlc.2016.10.019"},{"key":"50","doi-asserted-by":"crossref","unstructured":"52) World Medical Association: World Medical Association Declaration of Helsinki - ethical principles for medical research involving human subjects. J Am Heart Assoc, 2013; 310: 2191-2194","DOI":"10.1001\/jama.2013.281053"},{"key":"51","doi-asserted-by":"crossref","unstructured":"53) Ellis KL, Hooper AJ, Burnett JR, Watts GF: Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism. Nat Rev Endocrinol, 2016; 12: 467-484","DOI":"10.1038\/nrendo.2016.69"},{"key":"52","doi-asserted-by":"crossref","unstructured":"54) Haralambos K, Whatley S, Butler R, Datta D, Townsend D, Gingell R, Edwards R, Howard K, McDowell I: Familial Hypercholesterolaemia (FH) in Wales - Integrating R&D with Service Delivery (Conference Poster). 2013; http:\/\/www.fhservice.wales.nhs.uk\/sitesplus\/documents\/1072\/Conference Poster %282013%29.pdf","DOI":"10.1016\/j.atherosclerosis.2013.07.011"},{"key":"53","doi-asserted-by":"crossref","unstructured":"55) Haralambos K, Whitmore J: Using Pass Database and Geographic Information Systems (GIS) to map Familial Hypercholesterolaemia (FH) diagnoses and England and Wales. 2016; Unpublished Poster","DOI":"10.1016\/j.atherosclerosis.2016.09.050"},{"key":"54","doi-asserted-by":"crossref","unstructured":"56) Vallejo-Vaz A, Akram A, Kondapally Seshasaic S, Cole D, Watts G, Hovingh G, Kastelein J, Mata P, Raal F, Santos R, Soran H, Freiberger T, Abifadel M, Aguilar-Salinas C, Alnouri F, Alonso R, Al-Rasadi K, Banach M, Bogsrud M, Bourbon M, Bruckert E, Car J, Ceska R, Corral P, Descamps O, Dieplinger H, Do C, Durst R, Ezhov M, Fras Z, Gaita D, Gaspar I, Genest J, Harada-Shiba M, Jiang L, Kayikcioglu M, Lam C, Latkovskis G, Laufs U, Liberopoulos E, Lin J, Lin N, V M, Majano N, Marais A, M\u00e4rz W, Mirrakhimov E, Miserez A, Mitchenko O, Nawawi H, Nilsson L, Nordestgaard B, Paragh G, Petrulioniene Z, Pojskic B, Reiner Z, Sahebkar A, Santos L, Schunkert H, Shehab A, Slimane M, Stoll M, Su T, Susekov A, Tilney M, Tomlinson B, Tselepis A, Vohnoutbo B, Wid\u00e9n E, Yamashita S, Catapano A, Ray K: Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration. Atheroscler Suppl, 2016; 22: 1-32","DOI":"10.1016\/j.atherosclerosissup.2016.10.001"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/24\/10\/24_37507\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T19:56:38Z","timestamp":1692734198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/24\/10\/24_37507\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.37507","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}